New hope for endometriosis pain: phase 3 trial launches
NCT ID NCT07015268
First seen Mar 04, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This study tests a new drug, KLH-2109, to see if it works as well as a standard treatment (leuprorelin) for reducing pelvic pain in people with endometriosis. About 288 premenopausal women aged 18 and older with confirmed endometriosis will take part. The main goal is to measure changes in daily pain scores over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.